Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Copper Peptide (Prezatide Copper Acetate)
Overview
Prezatide Copper Acetate is a tripeptide-copper complex, most commonly represented by the sequence Gly-His-Lys bound to a copper ion. Copper peptides are proposed to enhance wound healing, collagen synthesis, and angiogenesis through modulation of matrix metalloproteinases and growth factor activity.
Mechanism of Action
The copper moiety is thought to play a critical role in stabilizing the peptide and serving as a cofactor for lysyl oxidase, an enzyme essential for collagen and elastin cross-linking.
Research Summary & Key Findings
Preclinical studies in rodent wound models have demonstrated accelerated re-epithelialization and increased tensile strength. Human studies, including small trials in patients with photoaged skin and surgical wounds, have shown improvements in scar appearance and dermal thickness, though large-scale randomized controlled trials are lacking.
Clinical Status
Copper Peptide (Prezatide Copper Acetate) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
References
Primary literature
- PubMed: "Copper Peptide"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov: "Copper Peptide"
Registered interventional and observational studies, including status and phase.
- PubChem: "Copper Peptide"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Dermatology
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine a...
View detailsArgireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter...
View detailsMatrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety t...
View detailsMatrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapept...
View detailsNo lawful pathway today
Copper Peptide (Prezatide Copper Acetate) is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States, so there is nothing for us to sell you here and no consultation to book. That can change: eight peptides moved back to a lawful pathway in February 2026.
Tell me if the status changes
One email, only if this compound's regulatory standing actually moves. Not a newsletter, not a sales sequence.
Join the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.